Market Access Sponsored Due diligence: Identifying start-up risks & gaps hVIVO's Consulting team discusses due diligence, a structured assessment process to evaluate an asset's risk, opportunities, and value drivers.
Digital Cyber resilience: Protecting tomorrow's therapies before the... As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
News Almost half of dementia cases could be prevented, says study A study has found that nearly half of all cases of dementia are avoidable with lifestyle changes, but current education campaigns have limited effect.
R&D Separating scientific risk assessment & consumer perception In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
Market Access Smoothing a contract pathway through uncertainty: In convers... Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.
Market Access Balancing efficiency with risks: How biopharma companies can... AI technologies can enable companies to program, rather than write, submissions to health authorities.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.